ANDA 203104, held by Twi Pharms. Donepezil Hydrochloride.
As of Nov 16, 2026, ANDA 203104 (Donepezil Hydrochloride), held by Twi Pharms, was first approved by FDA on Oct 29, 2014, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 29, 2014 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Donepezil Hydrochloride23MG · tablet;oral | Donepezil Hydrochloride | Rx |
| Sep 24, 2019 | Supplement 5Labeling · Standard review | Approved | None posted |
| Oct 4, 2016 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 29, 2014 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters